In addition, Leptin was significantly lower in the peripheral blood of the observation group (breast cancer patients who developed fatigue after chemotherapy) compared to the control group (breast cancer patients who did not develop fatigue after chemotherapy) (Fig. 1D). This evidence concerns the gene LEP and breast carcinoma.